Kanjinti

Kanjinti is used in adults either by itself or with other cancer medicines to treat specific types of breast cancer or stomach cancer.

Kanjinti is sometimes used when the cancer has spread to other parts of the body (metastatic).

Kanjinti may also be used for reasons not mentioned in this medication guide.

Do not use if you are pregnant. Use effective birth control.

Kanjinti can cause serious side effects, including infusion reactions and life-threatening heart and lung problems. Tell your doctor if you notice any symptoms like a new or worsening cough, dizziness, headaches, chest pain, trouble breathing, swelling, or rapid weight gain.

Tell your doctor if you have or have ever had:

• heart problems such as a heart attack, congestive heart failure, high blood pressure, and heart rhythm disorder;
• chemotherapy; or
• lung or breathing problems.

May cause birth defects or death to the unborn baby. Do not use if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control while receiving Kanjinti and for at least 7 months after your last dose. Tell your doctor if you become pregnant or think you may be pregnant.

It may not be safe to breastfeed while using this medicine, and for at least 7 months after your last dose. Ask your doctor about the risk.

Get emergency medical help if you have signs of an allergic reaction: hives, difficulty breathing, swelling of your face, lips, tongue, or throat.

Some side effects may occur during or within 24 hours of receiving this injection and may lead to serious lung problems. Tell your medical caregiver if you feel dizzy, nauseated, light-headed, itchy, sweaty, or have a headache, chest tightness, back pain, trouble breathing, or swelling in your face.

Tell your medical caregivers right away if you have:

• feeling like you might pass out;
• severe headache, blurred vision, pounding in your neck or ears;
• heart problems—pounding heartbeats, dizziness, loss of consciousness, swelling, cough, rapid weight gain (more than 5 pounds in 24 hours), new or worsening shortness of breath; or
• low blood cell counts—fever, chills, tiredness, mouth sores, skin sores, sore throat, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of Kanjinti may include:

• heart problems;
• nausea, diarrhea, weight loss;
• headache;
• sleep problems (insomnia), feeling tired;
• low blood cell counts;
• rash;
• fever, chills, cough, or other signs of infection;
• mouth sores or irritation;
• altered sense of taste; or
• cold symptoms such as stuffy nose, sneezing, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Your doctor will perform tests to make sure Kanjinti is the right treatment for you.

Kanjinti is given as an infusion into a vein. A healthcare provider will give you this injection.

Doses are based on weight. Your dose may change if you gain or lose weight.

Kanjinti is usually given once every 1 or 3 weeks. Your doctor will determine how long you should receive Kanjinti. Follow your doctor's dosing instructions very carefully.

You will be watched for a short time to make sure you do not have an allergic reaction or serious side effects.

You may need frequent medical tests and your cancer treatments may be delayed based on the results.

Your heart function may need to be checked before and during treatment with Kanjinti. You may also need heart function testing every 6 months for 2 years after your last dose of this medicine.

You may be given other medications to help prevent serious side effects or allergic reaction. Keep taking these medicines for as long as your doctor has prescribed.

Call your doctor for instructions if you miss an appointment for your Kanjinti.

In a medical setting, an overdose would be treated quickly.

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Kanjinti can have lasting effects on your heart, especially if you are receiving other cancer medications. Inform your doctor about all other cancer treatments you have had and are currently using.

Other medications may interact with Kanjinti, including prescription and over-the-counter drugs, vitamins, and herbal products. Let your doctor know about all other medicines you take.

Biosimilar and interchangeable products are biological products that are very similar to and have no significant differences from the reference product.

Reference products

These are biological products that have been approved by the FDA, which biosimilar products are compared to. There is 1 for Kanjinti.

Herceptin (trastuzumab) - Genentech, Inc.

View Herceptin information in detail.

Herceptin biosimilar products

Biosimilar products can only be given instead of the reference product if the healthcare provider specifically prescribes the biosimilar product by name.

Pharmacy laws for biosimilar prescribing may differ by state.

Hercessi (trastuzumab-strf) - Accord BioPharma Inc.

View Hercessi information in detail.

Herzuma (trastuzumab-pkrb) - CELLTRION, Inc.

View Herzuma information in detail.

Kanjinti (trastuzumab-anns) - Amgen Inc.

Ogivri (trastuzumab-dkst) - Biocon Biologics Inc.

View Ogivri information in detail.

Ontruzant (trastuzumab-dttb) - Samsung Bioepis Co., Ltd.

View Ontruzant information in detail.

Trazimera (trastuzumab-qyyp) - Pfizer Ireland Pharmaceuticals Unlimited Company

View Trazimera information in detail.